Cracking the Code: Biomarkers and the Fight Against Hormone Therapy ResistanceProfessor Andrew Tutt is a Consultant Clinical Oncologist in the Breast Cancer Unit at Guy's and St Thomas' NHS Foundation Trust. He is also a Professor of Oncology at King's College in London. We spoke to him about biomarkers for hormone therapy resistance and deficiency, and on targeting the Achilles heel in BRCA1 and BRCA2 gene mutations.Tune in for a deep dive into this important research.⁠⁠⁠⁠⁠⁠⁠Donate to Support Life-Saving Research⁠⁠⁠⁠⁠⁠⁠Like this episode? ⁠⁠⁠⁠⁠⁠⁠Find more Breast Cancer Trials Podcast Episodes here⁠⁠⁠⁠⁠⁠⁠Follow Breast Cancer Trials on Social Media: Instagram:⁠ ⁠⁠⁠⁠⁠⁠@breastcancertrials⁠⁠⁠⁠⁠⁠⁠ Facebook:⁠ ⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠⁠ LinkedIn: ⁠⁠⁠⁠⁠⁠⁠Breast Cancer Trials⁠⁠⁠⁠⁠⁠⁠ X: ⁠⁠⁠⁠⁠⁠⁠@BCTrialsANZ⁠⁠⁠⁠⁠⁠⁠Guest: Professor Andrew TuttThank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about the importance of breast cancer trials research. Find out more: ⁠⁠Breast Cancer Trials⁠⁠

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related